JACQUELINE SCHROEDER: Open Payments
NPI 1427810043 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 20 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $122 |
| Exact Sciences Corporation | 3 | $68 |
| Amgen Inc. | 3 | $49 |
| Astellas Pharma US Inc | 2 | $46 |
| ABBVIE INC. | 2 | $40 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: CAPLYTA, The Cologuard Plus Collection Kit, EVENITY, Veozah, QULIPTA, NEXLETOL, Rybelsus, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
